Search research articles
Contact Us
Filters
Showing results (621-630 of 635) with videos related to
Page
of 64
Sort By:
Gastroenterology
|
May 23, 2022
A Clinical Severity Index for Eosinophilic Esophagitis: Development, Consensus, and Future Directions
Evan S Dellon, Paneez Khoury, Amanda B Muir, et al.
Gastroenterology
|
October 23, 2021
Loss of Endothelial TSPAN12 Promotes Fibrostenotic Eosinophilic Esophagitis via Endothelial Cell-Fibroblast Crosstalk
Tetsuo Shoda, Ting Wen, Julie M Caldwell, et al.
The Lancet. Gastroenterology & Hepatology
|
March 2, 2023
One-food versus six-food elimination diet therapy for the treatment of eosinophilic oesophagitis: a multicentre, randomised, open-label trial
Kara L Kliewer, Nirmala Gonsalves, Evan S Dellon, et al.
Nature Medicine
|
July 23, 2013
Thymic stromal lymphopoietin-elicited basophil responses promote eosinophilic esophagitis
Mario Noti, Elia D Tait Wojno, Brian S Kim, et al.
Gastroenterology
|
March 27, 2022
Rio de Janeiro Global Consensus on Landmarks, Definitions, and Classifications in Barrett's Esophagus: World Endoscopy Organization Delphi Study
Fabian Emura, Viveksandeep Thoguluva Chandrasekar, Cesare Hassan, et al.
The Journal of Allergy and Clinical Immunology
|
April 12, 2011
Eosinophilic esophagitis: updated consensus recommendations for children and adults
Chris A Liacouras, Glenn T Furuta, Ikuo Hirano, et al.
The New England Journal of Medicine
|
May 29, 2009
Radiofrequency ablation in Barrett's esophagus with dysplasia
Nicholas J Shaheen, Prateek Sharma, Bergein F Overholt, et al.
Gastroenterology
|
June 18, 2011
Durability of radiofrequency ablation in Barrett's esophagus with dysplasia
Nicholas J Shaheen, Bergein F Overholt, Richard E Sampliner, et al.
Medrxiv : the Preprint Server for Health Sciences
|
January 8, 2026
Microbial Ecological Signatures Predict Pathogen Emergence and Multidrug Resistance in Cystic Fibrosis Airways up to a Year in Advance
Thomas R Goddard, Jessica Ap Carlson-Jones, Judith Morton, et al.
The Lancet. Gastroenterology & Hepatology
|
June 24, 2026
Dupilumab versus placebo in adults and adolescents with eosinophilic gastritis (DEGAS): a double-blind, placebo-controlled, phase 2, multicentre, randomised controlled trial
Nirmala P Gonsalves, Evan S Dellon, Kara L Kliewer, et al.
Page
of 64
Search research articles
Search
Showing results (621-630 of 635) with videos related to
Sort By:
Page
of 64
Gastroenterology
|
May 23, 2022
A Clinical Severity Index for Eosinophilic Esophagitis: Development, Consensus, and Future Directions
Evan S Dellon, Paneez Khoury, Amanda B Muir, et al.
Gastroenterology
|
October 23, 2021
Loss of Endothelial TSPAN12 Promotes Fibrostenotic Eosinophilic Esophagitis via Endothelial Cell-Fibroblast Crosstalk
Tetsuo Shoda, Ting Wen, Julie M Caldwell, et al.
The Lancet. Gastroenterology & Hepatology
|
March 2, 2023
One-food versus six-food elimination diet therapy for the treatment of eosinophilic oesophagitis: a multicentre, randomised, open-label trial
Kara L Kliewer, Nirmala Gonsalves, Evan S Dellon, et al.
Nature Medicine
|
July 23, 2013
Thymic stromal lymphopoietin-elicited basophil responses promote eosinophilic esophagitis
Mario Noti, Elia D Tait Wojno, Brian S Kim, et al.
Gastroenterology
|
March 27, 2022
Rio de Janeiro Global Consensus on Landmarks, Definitions, and Classifications in Barrett's Esophagus: World Endoscopy Organization Delphi Study
Fabian Emura, Viveksandeep Thoguluva Chandrasekar, Cesare Hassan, et al.
The Journal of Allergy and Clinical Immunology
|
April 12, 2011
Eosinophilic esophagitis: updated consensus recommendations for children and adults
Chris A Liacouras, Glenn T Furuta, Ikuo Hirano, et al.
The New England Journal of Medicine
|
May 29, 2009
Radiofrequency ablation in Barrett's esophagus with dysplasia
Nicholas J Shaheen, Prateek Sharma, Bergein F Overholt, et al.
Gastroenterology
|
June 18, 2011
Durability of radiofrequency ablation in Barrett's esophagus with dysplasia
Nicholas J Shaheen, Bergein F Overholt, Richard E Sampliner, et al.
Medrxiv : the Preprint Server for Health Sciences
|
January 8, 2026
Microbial Ecological Signatures Predict Pathogen Emergence and Multidrug Resistance in Cystic Fibrosis Airways up to a Year in Advance
Thomas R Goddard, Jessica Ap Carlson-Jones, Judith Morton, et al.
The Lancet. Gastroenterology & Hepatology
|
June 24, 2026
Dupilumab versus placebo in adults and adolescents with eosinophilic gastritis (DEGAS): a double-blind, placebo-controlled, phase 2, multicentre, randomised controlled trial
Nirmala P Gonsalves, Evan S Dellon, Kara L Kliewer, et al.
Page
of 64